InQuba Group Holding Company Limited Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: 09902260

INQUBA GROUP HOLDING COMPANY LIMITED

FILLETED UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

31 March 2025

INQUBA GROUP HOLDING COMPANY LIMITED

STATEMENT OF FINANCIAL POSITION

31 March 2025

	2025	2024
Note	£	£

Fixed assets

Investments	4	1,757	858

Current assets

Debtors	5	3,633,348	3,506,673
Cash at bank and in hand		46,709	239
		------------	------------
		3,680,057	3,506,912

Creditors: amounts falling due within one year	6	1,632,105	1,301,643
		------------	------------
Net current assets		2,047,952	2,205,269
		------------	------------
Total assets less current liabilities		2,049,709	2,206,127
		------------	------------
Net assets		2,049,709	2,206,127
		------------	------------

Capital and reserves

Called up share capital	7	215	205
Share premium account		2,118,738	2,117,847
Profit and loss account		( 69,244)	88,075
		------------	------------
Shareholders funds		2,049,709	2,206,127
		------------	------------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

INQUBA GROUP HOLDING COMPANY LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

31 March 2025

These financial statements were approved by the board of directors and authorised for issue on 27 November 2025 , and are signed on behalf of the board by:

Mr P Venkatesh

Director

Company registration number: 09902260

INQUBA GROUP HOLDING COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 MARCH 2025

1. General information

The company is a private company limited by shares, registered in England. The address of the registered office is 64 Baker Street, London, W1U 7GB, England.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Income tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Foreign currencies

Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.

Investments

Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.

Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.

Investments in associates

Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.

Investments in joint ventures

Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

Financial instruments

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities. Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability. Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

4. Investments

	Shares in group undertakings
	£
Cost
At 1 April 2024	857
Other movements	900
	-------
At 31 March 2025	1,757
	-------
Impairment
At 1 April 2024 and 31 March 2025	–
	-------

Carrying amount
At 31 March 2025	1,757
	-------
At 31 March 2024	857
	-------

Subsidiaries, associates and other investments

	Registered office	Class of share	Percentage of shares held
Subsidiary undertakings
InQuba America LLC	30 Wall Street	Ordinary	100
	8th Floor
	New York City
	New York
	United States of America
inQuba Australia Pty Limited	Suite 1802	Ordinary	100
	45 Clarence Street
	Syndey
	Australia
inQuba Europe Limited	64 Baker Street	Ordinary	100
	London
	W1U 7GB
	England

5. Debtors

	2025	2024
	£	£
Amounts owed by group undertakings and undertakings in which the company has a participating interest	3,586,228	3,506,673
Other debtors	47,120	–
	------------	------------
	3,633,348	3,506,673
	------------	------------

6. Creditors: amounts falling due within one year

	2025	2024
	£	£
Trade creditors	78,513	69,881
Amounts owed to group undertakings and undertakings in which the company has a participating interest	1,544,585	1,183,395
Corporation tax	3,849	46,490
Other creditors	5,158	1,877
	------------	------------
	1,632,105	1,301,643
	------------	------------

7. Called up share capital

Issued, called up and fully paid

	2025		2024
	No.	£	No.	£
Ordinary shares of £ 0.01 each	21,472	215	20,525	205
	--------	----	--------	----

The increase in share capital during the year reflects an allotment of shares completed on 18th November 2022 that has not previously been accounted for. This movement is not material and does not change the view of the accounts.

8. Related party transactions

The following loans were owed by/(owed to) related parties:

	2025	2024
	£	£
inQuba America LLC	1,130,518	1,049,310
inQuba Australia Pty Ltd	1,747,650	1,775,032
inQuba Europe Limited	708,060	682,331
inQuba Customer Intelligence (Pty) Limited	(1,380,049)	(1,183,395)
Clearline Investments Limited	(164,536)	–

The loans are unsecured, and repayable on demand, apart from the loan from Clearline Investments Limited, a shareholder in the company. This loan is subject to interest at 2.5% per month, repayable by 30th June 2025 and is secured by way of a charge over the book debts of the company.

9. Controlling party

As at the balance sheet date, the company was under the control of various entities through a shareholders agreement and as such no one party has ultimate control.